ASX Announcement - MIDKINE STRATEGY

29th August 2008, Sydney, Australia: Medical Therapies Limited has completed its strategy for the commercial development of its recently acquired Midkine Intellectual Property portfolio, the largest patent and patent application portfolio around Midkine globally. An outline of the plan is included here with key development milestones for potential revenue and value generation over the next two years.

This is a significant step in the Company’s progress signaling the commencement of the product development and commercialization program.  Since the acquisition of Midkine MTY, together with its expert advisors, has been refining its detailed strategy and business plan for this important therapeutic and diagnostic target to deliver maximum value for shareholders. 

To read more.... Download pdf here